SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

~~November~~Date ~~29,~~ of ~~2007~~Report (Date of earliest event reported)

December 14, 2007

Diomed Holdings, Inc.

Delaware

(State or other jurisdiction of incorporation)

000-32045

(Commission File Number)

84-1480636

(IRS Employer Identification No.)

1 Dundee Park

Andover, MA

(Address of Principal Executive Offices)

01810

(Zip Code)

Registrant’s telephone number, including area code: (978-475-7771)

~~ITEM~~Item 3 5.0102. ~~Notice~~Departure of ~~Delisting~~Directors or ~~Failure~~Certain toOfficers; ~~Satisfy~~Election aof ~~Continued~~Directors; ~~Listing~~Appointment ~~Rule~~of ~~or Standard;~~Certain ~~Transfer~~ Officers; Compensatory Arrangements of ~~Listing~~Certain Officers.

~~Following oral notice given to Diomed Holdings, Inc.~~ (~~the “Company”~~e) ~~on November 29, 2007~~ by the American Stock Exchange (“AMEX”), on December 3, 2007, the Company received a written notice (the “Notice”) from the AMEX advising the Company that it has failed to comply with Sections 1003(a)(ii) and (a)(iii) of the AMEX Company Guide’s standards for continued listing. The basis for the Notice is that the stockholder’s equity of the Company, as reported in the Company’s Quarterly Report on 10-QSB for the quarter ended September 30, 2007, is less than the $4,000,000 minimum required by Section 1003(a)(ii), with respect to an issuer with losses from continuing operations and/or net losses in three out its four most recent fiscal years, and is less than the $6,000,000 minimum required by Section 1003(a)(iii), with respect to an issuer with losses from continuing operations and/or net losses in its five most recent fiscal years. The Company’s stockholders’ equity as of September 30, 2007 was approximately $5,666,000.

InAt the ~~Notice,~~ recommendation ~~the~~of ~~AMEX invites~~ the ~~Company~~Compensation toCommittee ~~submit~~of to the ~~AMEX~~Board byof ~~January 3~~Directors, ~~2008~~on ~~a plan~~ December ~~setting forth the action that the Company has taken~~14, ~~or will take~~2007, ~~that would bring~~ the ~~Company~~Registrant ~~into~~increased ~~compliance~~the ~~with~~annual ~~this~~base ~~continued~~salary ~~listing~~of ~~standard~~William by D. ~~February 3~~ Allan, ~~2009.~~Managing ~~The~~Director ~~Company~~of ~~intends~~Diomed, ~~to submit such a plan to the AMEX as soon as practicable~~Ltd., ~~According~~ to ~~the Notice~~£113,000 ~~the~~per ~~AMEX~~annum, ~~will review the plan to~~effective ~~determine~~ retroactively ~~whether~~as ~~the Company has made a reasonable demonstration~~ of anNovember ~~ability to regain compliance with the continued listing standards within the specified timeframe~~1, ~~in which case the AMEX will accept the plan~~2007. IfIn ~~the~~making ~~AMEX~~this ~~accepts the plan~~determination, the ~~Company expects to continue its listing on the AMEX and to regain~~ ~~compliance~~ Compensation ~~with~~Committee ~~all~~considered, ~~AMEX~~among ~~continued~~other ~~listing criteria. If the AMEX does not accept the Company’s plan~~things, ~~or if~~ the ~~Company~~fact ~~does~~that ~~not make progress consistent with the~~Mr. ~~plan~~ Allan and orhis ~~regain~~family ~~compliance~~recently ~~with~~relocated ~~the~~to ~~continued listing standards within~~ the ~~applicable~~ ~~time period~~Cambridge, ~~then~~England ~~the~~area ~~AMEX~~in ~~may initiate proceedings~~ order to ~~delist the~~ ~~Company’s~~ serve ~~common stock from~~ the ~~AMEX~~Registrant.

AAlso ~~copy~~ at the recommendation of the ~~Notice~~Compensation isCommittee, ~~attached~~on ~~hereto~~December as19, ~~Exhibit~~2007, 99the Registrant extended its employment agreement with its Chief Executive Officer, James A.1 Wylie, ~~and~~Jr. for a ~~copy~~term of ~~the~~one ~~Company’s~~year ~~press release~~through ~~regarding~~December ~~receipt~~31, 2008. All other terms of ~~the~~Mr. ~~Notice~~Wylie’s isemployment ~~attached~~agreement ~~hereto~~remain asin ~~Exhibit~~effect and 99 unmodified.2.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

99.1	Letter from AMEX to Diomed Holdings, Inc. dated December 3, 2007
99.2	Press Release by Diomed Holdings, Inc. dated December 4, 2007

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Diomed Holdings, Inc.
	Diomed Holdings, Inc. (Registrant)
	(Registrant)
Date: December 19, 2007	By:	/s/ DAVID B. SWANK
Date: December 4, 2007	By:	/s/ DAVID B. SWANK
		Name: David B. Swank.
	Name:	David B. Swank
		Title: Chief Financial Officer
	Title:	Chief Financial Officer

List of Exhibits:

99.1	Letter from AMEX to Diomed Holdings, Inc. dated December 3, 2007
99.2	Press Release by Diomed Holdings, Inc. dated December 4, 2007

Filing Compare · DIOMED HOLDINGS INC